Sangamo Therapeutics
SGMOSangamo Therapeutics, Inc. (previously known as Sangamo Biosciences, Inc.) is an American biotechnology company based in Brisbane, California. It applies cell and gene therapy to combat haemophilia and other genetic diseases.
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2022-2024
All insider trades at Sangamo Therapeutics
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 9/26/2023 | Sell | Idec Pharmaceuticals Corp | Ten Percent Owner | $0.5 | $3,000,000 |
| 8/30/2022 | Sell | Idec Pharmaceuticals Corp | Ten Percent Owner | $5.3 | $526,520 |
| 8/29/2022 | Sell | Idec Pharmaceuticals Corp | Ten Percent Owner | $5.3 | $2,130,720 |
| 6/3/2022 | Buy | Markels, John | Director | $3.7 | $25,029 |
| 6/1/2022 | Buy | Parker, H Stewart | Director | $3.6 | $17,996 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)